Sodium butyrate induces alkaline phosphatase gene expression in human hepatoma cells

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 2, 1999, Pages 156-162

  Khan, Khaleque Newaz ^a   Tsutsumi, Takuya ^a   Nakata, Keisuke ^b   Kato, Yuji ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Alkaline phosphatase; Liver bone kidney alkaline phosphatase; Short chain fatty acid; Sodium butyrate

Indexed keywords

ALKALINE PHOSPHATASE; BUTYRIC ACID; COMPLEMENTARY DNA; MESSENGER RNA; THYMIDINE; TRITIUM;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0032911394     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.01818.x     Document Type: Article

References (53)

1. 1 Leder A, Leder P. Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells. Cell 1975; 5: 319-22.
2. 2 Vidali G, Boffa LC, Bradburry EM, Allfrey VG. Butyrate suppression of histone deacetylation leads to accumulation of multiacetylated forms of histone H3 and H4 and increased DNase I sensitivity of the associated DNA sequences. Proc. Natl Acad. Sci. USA 1978; 75: 2239-43.
3. 3 Kruh J. Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol. Cell. Biochem. 1982; 42: 65-82.
4. 4 Samuels HH, Stanley F, Casanova J, Shao TC. Thyroid hormone nuclear receptor levels are influenced by the acetylation of chromatin-associated proteins. J. Biol. Chem. 1980; 255: 2499-508.
5. 5 Cousens LS, Gallwitz D, Alberts BM. Different accessibilities in chromatin to histone acerylase. J. Biol. Chem. 1979; 254: 1716-23.
6. 6 Sterner R, Vidali G, Allfrey VG. Studies of acetylation and deacetylation in high mobility group proteins. J. Biol. Chem. 1981; 256: 8892-5.
7. 7 Boffa LC, Gruss RJ, Allfrey VG. Manifold effects of sodium butyrate on nuclear function. J. Biol. Chem. 1981; 256: 9612-21.
8. 8 Sealy L, Chalkey R. The effect of sodium butyrate on histone modification. Cell 1978; 14: 115-21.
9. 9 Verney M, Marty J, Moatti J-P. Absorption of electrolytes and volatile fatty acids in the hind-gut of the rabbit: Circadian rhythm of hind-gut electrolytes and plasma aldosterone. Br. J. Nutr. 1984; 52: 419-28.
10. 10 Cummings JH. Short chain fatty acids in the human colon. Gut 1981; 22: 763-79.
11. 11 McComb RB, Posen S. Alkaline phosphatases. New York: Plenum Publishing Corp., 1979.
12. 12 Harris H. The Harvey Lecture's: Series 76. Orlando: Academy Press, 1982.
13. 13 Goldstein DJ, Rogers C, Harris H. A search for trace expression of placental-like alkaline phosphatase in non-malignant human tissues: demonstration of its occurrence in lung, cervix, testis and thymus. Clin. Chem. Acta 1982; 125: 63-75.
14. 14 Kiledjian M, Kadesch T. Analysis of the human liver/bone/kidney alkaline phosphatase promoter in vivo and in vitro. Nucl. Acids Res. 1990; 18: 957-61.
15. 15 Kiledjian M, Kadesch T. Post transcriptional regulation of the human liver/bone/kidney alkaline phosphatase gene. J. Biol Chem. 1991; 266: 4207-13.
16. 16 Kaplan MM, Righetti A. Induction of rat liver alkaline phosphatase: The mechanism of the serum elevation in bile duct obstruction. J. Clin. Invest. 1970; 49: 508-16.
17. 17 Seetharam S, Sussman NL, Komoda T, Alpers DH. The mechanism of elevated alkaline phosphatase activity after bile duct ligation in the rat. Hepatology 1986; 6: 374-80.
18. 18 Cummings JH, Pomare EW, Branch WJ, Naylor CPE, Macfarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987; 28: 1221-7.
19. 19 Candido EPM, Reeves R, Davie JR. Sodium butyrate inhibits histone deacetylation in cultured cells. Cell 1978; 14: 105-13.
20. 20 Norton VG, Imai BS, Yau P, Bradbury EM. Histone acetylation reduces nucleosome core particle linking number change. Cell 1989; 57: 449-57.
21. 21 Gum JR, Kam WK, Byrd JC, Hicks JW, Sleisenger MH, Kim YS. Effect of sodium butyrate on human colonic adenocarcinoma cells: Induction of placental-like alkaline phosphatase. J. Biol. Chem. 1987; 262: 1092-7.
22. 22 Langdon SP, Hawkes MM, Hay FG et al. Effect of sodium butyrate and other differentiation inducers on poorly dif-ferentiated human ovarian adenocarcinoma cell lines. Cancer Res. 1988; 48: 6161-5.
23. 23 Morita A, Tsao D, Kim YS. Effect of sodium butyrate on alkaline phosphatase in HRT-18, a human rectal cancer cell line. Cancer Res. 1982; 42: 4540-5.
24. 24 Tsao D, Morita A, Bella JR, Luu P, Kim YS. Differential effects of sodium butyrate, dimethyl sulfoxide and retinoic acid on membrane-associated antigen, enzymes and glycoproteins of human rectal adenocarcinoma cells. Cancer Res. 1982; 42: 1052-8.
25. 25 Deng G, Liu G, Hu L, Gum Jr JR, Kim YS. Transcriptional regulation of the human placental-like alkaline phosphatase gene and mechanisms involved in its induction by sodium butyrate. Cancer Res. 1992; 52: 3378-83.
26. 26 Kim YS, Tsao D, Siddiqui B et al. Effects of sodium butyrate and dimethylsulfoxide on biochemical properties of human colon cancer cells. Cancer 1980; 45: 1185-92.
27. 27 Daniel P, Brazier M, Cerutti I et al. Pharmacokinetic study of butyric acid administration in vivo as sodium and arginine butyrate salts. Clin. Chim. Acta 1989; 181: 255-64.
28. 28 Nakagawa T, Nakao Y, Matsui T et al. Effects of sodium n-butyrate on alpha-fetoprotein and albumin secretion in the human hepatoma cell line PLC/PRF/5. Br. J. Cancer 1985; 51: 357-63.
29. 29 Saito H, Morizane T, Watanabe T et al. Differentiating effect of sodium butyrate on human hepatoma cell lines PLC/PRF/5, HCC-M, and HCC-T. Int. J. Cancer 1991; 48: 291-6.
30. 30 Tsutsumi T, Ido A, Nakao K et al. Reciprocal regulation of α-fetoprotein and albumin gene expression by butyrate in human hepatoma cells. Gastroenterology 1994; 107: 499-504.
31. 31 Smith TJ, Piscatelli JJ, Andersen V, Wang HS, Lance P. n-Butyrate induces plasminogen activator inhibitor type 1 messenger RNA in cultured HepG2 cells. Hepatology 1996; 23: 866-71.
32. 32 Shah S, Lance P, Smith TJ et al. n-Butyrate reduces the expression of β-galactoside α-2,6-sialyltransferase in HepG2 cells. J. Biol. Chem. 1992; 267: 10652-8.
33. 33 Terao M, Mintz B. Cloning and characterization of a cDNA coding for mouse placental alkaline phosphatase. Proc. Natl Acad. Sci. USA 1987; 84: 7051-5.
34. 34 Khan KN, Tsutsumi T, Nakata K, Nakao K, Kato Y, Nagataki S. Regulation of alkaline phosphatase gene expression in human hepatoma cells by bile acids. J. Gastroenterol. Hepatol. 1998; 13: 643-50.
35. 35 Nakabayashi H, Taketa K, Yamane T, Miyazaki M, Miyano K, Sato J. Phenotypical stability of a human hepatoma cell line, HuH-7, in long term culture with chemically defined medium. Gann 1984; 75: 151-8.
36. 36 Bowers Jr GN, McComb RB. A continuous spectrophotometric method for measuring the activity of serum alkaline phosphatase. Clin. Chem. 1966; 12: 70.
37. 37 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 1976; 72: 248-54.
38. 38 Weiss MJ, Henthorn PS, Lafferty MA, Slaughter C, Raducha M, Harris H. Isolation and characterization of a cDNA encoding a human liver/bone/kidney-type alkaline phosphatase. Proc. Natl Acad. Sci. USA 1986; 83: 7182-6.
39. 39 Matsuura S, Kishi F, Kajii T. Characterization of a 5′-flanking region of the human liver/bone/kidney alkaline phosphatase gene:Two kinds of mRNA from a single gene. Biochem. Biophys. Res. Commun. 1990; 168: 993-1000.
40. 40 Schenk WG, McDonald JC, McDonald K, Draponas T. Direct measurement of hepatic blood flow in surgical patients. Ann. Surg. 1962; 156: 463-9.
41. 41 Jenkins WJ, Billing B. Physiology of the liver. In: Berk JE, ed. Bockus Gastroenterology Vol. 5, 4th edn. Philadelphia: Saunders, 1985; 2666-96.
42. 42 Miller AA1 Kurschel E, Osieka R, Schmidt CG. Clinical pharmacology of sodium butyrate in patients with acute leukemia. FMI: J. Cancer CHn. Oncol. 1987; 23: 1283-7.
43. 43 Velazquez OC, Jabbar A, DeMatteo RP, Rombeau JL. Butyrate inhibits seeding and growth of colorectal metastasis to the liver in mice. Surgery 1996; 120: 440-8.
44. 44 Marks PA, Rifkind RA. Differentiation inducers. Cancer 1984; 54: 2766-9.
45. 45 De Haan JB, Gevers W, Parker MI. Effects of sodium butyrate on the synthesis and methylation of DNA in normal cells and their transformed counterparts. Cancer Res. 1986; 46: 713-16.
46. 46 Kyritsis A, Joseph G, Chader GJ. Effects of butyrate, retinol and retinoic acid on human Y-79 retinoblastoma cells growing in monolayer cultures. J. Natl Cancer Inst. 1984; 73: 649-04.
47. 47 Bell L, Williams L. Histochemical demonstration of alkaline phosphatase in human large intestine, normal and diseased. Histochemistry 1979; 60: 85-9.
48. 48 McGinty F, Delides G, Harrison D. The significance of enzyme histochemical patterns in carcinomas of the large intestine in man. Gut 1973; 14: 502-5.
49. 49 Bader AV, Kondratick J, Bader JP. Decreased alkaline phosphatase in cells transformed by Rous sarcoma virus. Cancer Res. 1978; 38: 303-12.
50. 50 Chou JY. Human placental cells transformed by tsA mutants of simian virus 40: A model system for the study of placental functions. Prof. Natl Acati. Sci. USA 1978; 75: 1409-13.
51. 51 Sella BA, Sachs L. Alkaline phosphatase activity and the regulation of growth in transformed mammalian cells. J. Cell Physiol. 1974; 83: 27-34.
52. 52 Weiss MJ, Ray K, Henthorn PS, Lamb B, Kadesch T, Harris H. Structure of the human liver/bone kidney alkaline phosphatase gene. J. Biol. Chem. 1988; 263: 12002-10.
53. 53 Telfer JF, Green CD. Induction of germ-cell alkaline phosphatase by butyrate and cyclic AMP in BeWo choriocarcinoma cells. Biochem. J. 1993; 296: 59-65.